PRF Technologies (PRFX) Research & Development (2020 - 2025)
PRF Technologies' (PRFX) quarterly Research & Development came in at $2000.0 in Q2 2025, down 99.96% on a YoY basis from $4.7 million in Q2 2024, and down 99.96% quarter-over-quarter from $4.7 million in Q2 2024.
Powered by 
Analysis
PRF Technologies (PRFX) Research & Development (2020 - 2025) Analysis & Trends
PRF Technologies (PRFX) has reported Research & Development for 6 consecutive years, with $2000.0 the latest figure, recorded in Q2 2025.
- For the quarter ending Q2 2025, Research & Development fell 99.96% year-over-year to $2000.0; the trailing twelve-month figure through Jun 2025 stood at -$2.7 million (up 68.63% YoY), and the FY2025 full-year result was -$1.1 million, up 90.29% from the prior year.
- Research & Development eased to $2000.0 in Q2 2025 per PRFX's latest filing, from $4.7 million in the prior quarter.
- Across five years, Research & Development topped out at $6.9 million in Q4 2022 and bottomed at -$6.0 million in Q3 2023.
- Historically, Research & Development has averaged $83600.0 across 5 years, with a median of -$680000.0 in 2022.
- The widest YoY moves for Research & Development: up 3001.12% in 2021, down 4187.5% in 2021.
- Over 5 years, Research & Development stood at $5.2 million in 2021, then jumped by 33.52% to $6.9 million in 2022, then slumped by 139.83% to -$2.7 million in 2023, then surged by 272.87% to $4.7 million in 2024, then plunged by 99.96% to $2000.0 in 2025.
- According to Business Quant data, Research & Development over the past three periods registered $2000.0, $4.7 million, and -$4.7 million for Q2 2025, Q2 2024, and Q1 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 46.72 Bn | 43.07 Bn | 2.15 Bn | 970.00 Mn |
| 2 | Viatris | 19.64 Bn | 18.75 Bn | 1.46 Bn | 248.30 Mn |
| 3 | Dr Reddys Laboratories | 10.36 Bn | 10.22 Bn | 396.53 Mn | 60.90 Mn |
| 4 | Amneal Pharmaceuticals | 6.44 Bn | 6.39 Bn | 334.51 Mn | 39.02 Mn |
| 5 | Bausch Health Companies | 2.11 Bn | 1.24 Bn | 2.10 Bn | 173.00 Mn |
| 6 | Ani Pharmaceuticals | 1.88 Bn | 1.52 Bn | 165.89 Mn | 14.75 Mn |
| 7 | Alvotech | 1.83 Bn | 1.69 Bn | 2.56 Mn | -21.86 Mn |
| 8 | Amphastar Pharmaceuticals | 1.04 Bn | 751.07 Mn | 93.47 Mn | 22.16 Mn |
| 9 | Fennec Pharmaceuticals | 382.22 Mn | 340.97 Mn | 17.15 Mn | 10.66 Mn |
| 10 | PRF Technologies | 622,054.07 | -10.31 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 2,000.00 |
| Jun 30, 2024 | 4.75 Mn |
| Mar 31, 2024 | -4.74 Mn |
| Dec 31, 2023 | -2.75 Mn |
| Sep 30, 2023 | -5.99 Mn |
| Jun 30, 2023 | 4.15 Mn |
| Mar 31, 2023 | -1.45 Mn |
| Dec 31, 2022 | 6.90 Mn |
| Sep 30, 2022 | -3.90 Mn |
| Jun 30, 2022 | 2.10 Mn |
| Mar 31, 2022 | -680,000.00 |
| Dec 31, 2021 | 5.16 Mn |
| Sep 30, 2021 | -4.04 Mn |
| Jun 30, 2021 | 2.76 Mn |
| Mar 31, 2021 | -1.03 Mn |
| Dec 31, 2020 | 446,000.00 |
| Sep 30, 2020 | -157,000.00 |
| Jun 30, 2020 | 89,000.00 |
| Mar 31, 2020 | -24,000.00 |
API Access
PRF Technologies Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=PRFX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "PRFX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=PRFX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();